Restoring Upright Mobility After Spinal Cord Injury

May 19, 2023 updated by: University Health Network, Toronto

Restoring Upright Mobility After Spinal Cord Injury Using Functional Electrical Stimulation

Up to 15 able-bodied individuals will participate in one testing session to evaluate the effectiveness of the A-FES system. Up to 20 individuals with SCI will participate in 12 sessions of A-FES therapy. At each session, participants will stand on a force plate (Accu Sway, AMTI, USA) with the A-FES system (Compex Motion II, Compex Motion, Switzerland) donned. The centre of pressure (COP) will be calculated in real time using the force plate data. The calculated COP will be presented to participants on a monitor and they will be instructed to shift their COP in the indicated directions as represented by a cursor (i.e. training with visual feedback). The intensity of electrical stimulation provided by the A-FES system will be regulated by the measured COP in a closed-loop manner. In this study we propose to develop and evaluate the clinically-feasible A-FES system for the training of standing balance.

Study Overview

Study Type

Interventional

Enrollment (Actual)

5

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M4G 3V9
        • Lyndhurst Centre, Toronto Rehabilitation Institute-UHN

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. A traumatic or non-traumatic, non-progressive (AIS) C or D SCI;
  2. ≥18 years old;
  3. Able to stand independently for 60s;
  4. Moderate level of trunk control as evidenced by the ability to reach forward >2 inches in standing (i.e. score of 2 on the BBS Reaching Forward task50,51); and
  5. Free of any other condition besides SCI that significantly affects walking or balance (e.g., no vestibular disorder, significant vision loss, stroke).

Exclusion Criteria:

  1. Severe spasticity in the legs;
  2. Contractures in the lower extremities that prevent achieving a neutral hip and ankle position, or extended knee;
  3. A prior lower extremity fragility fracture;
  4. An injection of botulinum toxin to leg muscles in the past six months;
  5. Peripheral nerve damage in the legs (i.e. leg muscles unresponsive to electrical stimulation);
  6. A pressure sore (>grade 2) on the pelvis or trunk where the safety harness is applied; o
  7. Contraindications for FES52 (i.e. implanted electronic device, active cancer or radiation in past 6 months, epilepsy, skin rash/wound at a potential electrode site).

Participants will be withdrawn from the study if FES irritates their skin.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Berg Balance Scale
Time Frame: Change from Baseline Berg Balance Scale at 8 weeks
Assesses static and dynamic standing balance; score 0-56; higher score means a better outcome
Change from Baseline Berg Balance Scale at 8 weeks
Mini-Balance Evaluation Systems Test
Time Frame: Change from Baseline Mini-Balance Evaluation Systems Test at 8 weeks
Assesses four balance control systems, including anticipatory balance, reactive postural control, sensory orientation and dynamic gait
Change from Baseline Mini-Balance Evaluation Systems Test at 8 weeks
Activities-specific Balance Confidence Scale
Time Frame: Change from Baseline Activities-specific Balance Confidence Scale at 8 weeks
A measure of balance self-efficacy; mean score of 0-100; higher score means a better outcome (i.e. high balance confidence)
Change from Baseline Activities-specific Balance Confidence Scale at 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Static standing balance
Time Frame: Through study completion, average of 8 weeks
Postural sway during quiet standing
Through study completion, average of 8 weeks
Dynamic standing balance
Time Frame: Through study completion, average of 8 weeks
Assessed by asking participants to lean as far as possible in the forward, backward and sideways directions while standing on a force plate (i.e. limits of stability test)
Through study completion, average of 8 weeks
Semi-structured interview
Time Frame: up to 8 weeks post-intervention
The guide will include open-ended questions concerning the participant's experience with, and impressions of, A-FES therapy
up to 8 weeks post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kristin E Musselman, PhD, University of Toronto

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 30, 2017

Primary Completion (Actual)

November 14, 2018

Study Completion (Actual)

June 5, 2019

Study Registration Dates

First Submitted

February 4, 2020

First Submitted That Met QC Criteria

February 7, 2020

First Posted (Actual)

February 10, 2020

Study Record Updates

Last Update Posted (Actual)

May 23, 2023

Last Update Submitted That Met QC Criteria

May 19, 2023

Last Verified

February 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Cord Diseases

Clinical Trials on Functional Electrical Stimulation

3
Subscribe